Blog
Klow Peptide Benefits: What Four Peptides Do, Study by Study (2026)
What the Klow blend of GHK-Cu, BPC-157, TB-500 and KPV is studied for, peptide by peptide, from skin and tendon repair to gut inflammation and hair, and how fast each change showed.
Most people meet Klow as a list of promises: firmer skin, faster healing, a calmer gut, thicker hair, and now and then weight loss. The list runs long because Klow is four peptides in one vial, and every promise on it belongs to one of the four.
That is also the fair way to judge it. No study has tested Klow as a blend. Each part carries its own record, and the records are far from equal: GHK-Cu has skin trials in people, thymosin beta-4 (the parent of TB-500) has reached a 73-patient trial on leg ulcers, BPC-157 rests on rat tendon work and a few small human reports, and KPV lives almost entirely in mouse models of colitis. Simms Research sells the Klow Peptide Blend as one 80mg vial for $122, and its latest certificate weighs all four peptides one by one.
What is Klow peptide?
A freeze-dried research blend of four peptides at a fixed 5 : 1 : 1 : 1 ratio: 50mg of GHK-Cu, 10mg of BPC-157, 10mg of TB-500 and 10mg of KPV. The copper in GHK-Cu turns the powder blue. The first three are the same repair base sold as Glow; KPV is the addition, and the one peptide in the vial aimed at inflammation rather than rebuilding.
| Peptide in Klow | What it is | Studied for | Strongest evidence |
|---|---|---|---|
| GHK-Cu, 50mg | Copper-binding tripeptide found in human plasma | Skin collagen, wound closure, hair | Topical skin trials in people |
| BPC-157, 10mg | 15-amino-acid fragment of a gastric protein | Tendon, ligament, muscle and gut repair | Rat injury models; small human case series |
| TB-500, 10mg | Synthetic peptide built on the actin-binding region of thymosin beta-4 | Cell migration, wound closure, hair | Rodent wounds; human trials of full thymosin beta-4 |
| KPV, 10mg | Last three amino acids of alpha-MSH (Lys-Pro-Val) | Gut and skin inflammation | Mouse colitis models |
Read across the table and the blend’s logic is plain. GHK-Cu, BPC-157 and TB-500 work on rebuilding tissue: collagen, new blood vessels, cells crawling into a wound. KPV works on the signal that keeps tissue inflamed. The benefits below follow the same split.

Klow peptide benefits for skin
Skin is the best-supported benefit in the blend, and nearly all of it comes from GHK-Cu, the largest share of the vial. It also has the most human data behind it. A GHK-Cu facial cream used for 12 weeks by 71 women with sun-aged skin left it denser and thicker, with less sagging, fewer fine lines and shallower wrinkles (Pickart and Margolina, International Journal of Molecular Sciences, 2018). Those trials put copper peptide on the skin, not under it, so they show what the molecule can do in people rather than what a research vial does.
The animal work explains the mechanism. On open wounds cut into skin with a poor blood supply, a copper tripeptide gel shrank the wound by 64.5% in 13 days, against 28.2% for untreated rats, and the treated tissue held less TNF-alpha and fewer collagen-breaking enzymes (Canapp et al., Veterinary Surgery, 2003). TB-500 adds to that in older skin: in 26-month-old mice, whose wounds closed slowly, thymosin beta-4 sped healing, and LKKTETQ, the seven-amino-acid actin-binding piece that TB-500 is built on, did about as well as the whole protein (Philp et al., Wound Repair and Regeneration, 2003).
KPV counts for skin only when the skin is inflamed or infected. For smooth, sun-aged skin the collagen work is GHK-Cu’s, and Glow vs Klow sets out when the extra peptide earns its place.

Tendon, ligament and wound healing
Healing is where three of the four peptides overlap, and where most of the animal evidence sits. BPC-157 has the tendon record. Rats with a cut Achilles tendon given 10mcg per kilogram a day healed with stronger tendons, better walking scores and more organised collagen over two weeks, while untreated rats healed poorly (Staresinic et al., Journal of Orthopaedic Research, 2003). In tendon cells it sped migration and spreading and kept cells alive under oxidative stress, through the FAK-paxillin pathway that cells use to grip and move (Chang et al., Journal of Applied Physiology, 2011).
Thymosin beta-4 works on the same step from another side: getting repair cells into the wound. Put on full-thickness wounds in rats or given by injection, it raised new skin cover 42% over saline by day four and up to 61% by day seven, with more collagen and more new vessels (Malinda et al., Journal of Investigative Dermatology, 1999). Most of that record used the full 43-amino-acid protein; TB-500 carries its active region.
Human data is thin but real. In a chart review of 16 people with knee pain given BPC-157 into the joint, 11 of the 12 who had BPC-157 alone reported clear relief, with no comparison group (Lee and Padgett, Alternative Therapies in Health and Medicine, 2021). Thymosin beta-4 has gone further: in a placebo-controlled trial across eight European sites, 73 patients with venous leg ulcers used a thymosin gel, its safety matched placebo, and about a quarter on the 0.03% strength healed fully within three months (Guarnera et al., Annals of the New York Academy of Sciences, 2010).
Gut health and inflammation
The gut is KPV’s ground, with BPC-157 behind it. KPV rides into gut-lining and immune cells on PepT1, a small-peptide carrier that an inflamed colon switches on, and once inside it damps NF-kappaB, one of the master switches for inflammatory signals. Given in drinking water, it eased two different forms of chemically induced colitis in mice (Dalmasso et al., Gastroenterology, 2008). A second group found treated mice bounced back sooner and put their lost weight back on, and in mice lacking MC1R, the receptor behind tanning, KPV kept every treated animal alive (Kannengiesser et al., Inflammatory Bowel Diseases, 2008). Packed into hyaluronic-acid nanoparticles and swallowed, KPV reached the colon wall and calmed ulcerative colitis in mice (Xiao et al., Molecular Therapy, 2017).
BPC-157 started life in the stomach: it is a piece of a protein isolated from human gastric juice, and by the early 2000s it had entered trials for inflammatory bowel disease under the code PL 14736 (Staresinic et al., Journal of Orthopaedic Research, 2003). Two limits stand. The KPV colitis work gave the peptide by mouth, straight to the colon. And none of it has been repeated in people, so gut comfort is the most talked-about Klow benefit with the least human data behind it.
Klow peptide benefits for hair
Plausible, from two of the four peptides, and so far only in lab models. AHK-Cu, a close copper-peptide relative of GHK-Cu, lengthened human hair follicles kept alive in culture and multiplied the dermal papilla cells that drive a follicle’s growth (Pyo et al., Archives of Pharmacal Research, 2007). Thymosin beta-4 grew hair in both young and aged rodents, through the same new vessels and cell movement it drives in wounds (Philp et al., Mechanisms of Ageing and Development, 2004).
BPC-157 and KPV have no hair research at all, and no one has put Klow itself on a scalp. For hair, the 50mg of GHK-Cu is the part that counts, and the same amount sits in a Glow vial or a plain GHK-Cu vial.

Klow benefits timeline
Days for open wounds, about two weeks for tendons, three months for skin and chronic ulcers. Those are the studies’ own clocks, read at the point each one measured a change:
| Change | Peptide and model | When measured |
|---|---|---|
| New skin over a wound, up 42% | Thymosin beta-4, rats | Day 4 (up to 61% by day 7) |
| Wound area down 64.5% | Copper tripeptide gel, rats | Day 13 |
| Stronger, better-working Achilles tendon | BPC-157, rats | Days 1 to 14 |
| Denser skin, fewer fine lines | GHK-Cu cream, 71 women | 12 weeks |
| Leg ulcers fully closed in about a quarter | Thymosin beta-4 gel, 73 patients | Within 3 months |
Rats heal several times faster than people, so the animal timings are the earliest a change could show, not a forecast. The human numbers are the better guide: skin and slow wounds were judged over 12 weeks. The Klow dosage chart covers how often and for how long.
Klow and weight loss: what it does not do
Klow is not a weight-loss peptide. None of its four parts acts on appetite, and the only fat-storage work is one lab’s 2026 KPV studies in fat cells and high-fat-diet mice. The mice that regained weight in the KPV colitis work were recovering from illness, not losing fat.
It does not build muscle either: faster tendon and muscle repair in rats is recovery, not growth. It does not tan, because KPV is the tail of alpha-MSH and leaves out the part that darkens skin. And the blend itself has never been tested, so no study shows the four working better together than apart. The case for combining them is practical: four peptides aimed at one repair job, drawn from one vial.
Klow peptide benefits for women and men
The research does not split by sex; what differs is what people want from the blend. Women mostly come to Klow for skin, and that happens to be its best-backed benefit: the 12-week GHK-Cu cream trial was run in women. Men mostly come for tendon, joint and training recovery, which leans on the rat tendon work and the small knee-pain series.
Who Klow suits comes down to the job. Repair research with inflammation in the picture, such as irritated skin, a slow wound or a gut model, uses all four peptides. Collagen or hair work runs just as well on Glow.
What is in a Klow vial, measured
All four peptides, each at or above its label, in Simms Research’s July 2026 batch. Every benefit above belongs to one peptide, and a blend’s blue colour proves only that the copper is there, so the certificate has to show the other three. On the lab’s chromatogram the blend splits into four clean peaks: GHK-Cu leaves the column at about 4 minutes, KPV at about 6, BPC-157 near 15 and TB-500 near 18. Each peak was weighed:
| Peptide | Label | Measured | Benefit it carries |
|---|---|---|---|
| GHK-Cu | 50mg | 55.84mg | Skin, wound closure, hair |
| BPC-157 | 10mg | 11.17mg | Tendon, ligament, gut |
| TB-500 | 10mg | 10.82mg | Cell migration, wound closure |
| KPV | 10mg | 10.32mg | Gut and skin inflammation |
Three vials from the batch were tested, averaging 99.647% purity, with identity confirmed by mass spectrometry and clean endotoxin, heavy-metal and sterility screens. The full certificate sits on the Klow lab results page, and How to Read a Peptide Certificate of Analysis explains each line. For water, units and how long a vial lasts, use the Klow dosage chart; the Klow Peptide Blend itself is $122 for the 80mg vial, and the rest of the range is in the Simms Research shop.
Frequently asked questions
Is Klow peptide safe, and what are the side effects?
The common complaint is minor: a brief sting from the copper in GHK-Cu as the solution goes in. The human safety data on the parts is reassuring. Healthy volunteers given thymosin beta-4 into a vein at up to 1,260mg a day for 14 days tolerated it well (Ruff et al., Annals of the New York Academy of Sciences, 2010), and two adults infused with 10mg and then 20mg of BPC-157 showed no change in heart, liver, kidney, thyroid or blood-sugar markers (Lee and Burgess, Alternative Therapies in Health and Medicine, 2025).
What do Klow before and after results show?
No before-and-after study of the blend exists. The measured results come from its parts: skin judged after 12 weeks of GHK-Cu cream and ulcers after three months of thymosin gel. Photos online can’t separate the blend from everything else a person changed in the same weeks.
Is Simms Research legit?
Simms Research posts batch reports from an independent ISO-certified lab, and the latest Klow report weighs each of its four peptides across three vials. Orders placed before 5PM Eastern ship the same day; UPS Standard takes 3 to 5 business days and FedEx 2-Day is free over $200. Every order carries a Free Delivery Guarantee: a parcel lost in transit, stolen after a delivery scan or damaged is replaced at no charge, with no carrier claim to file. Support answers at support@simmsresearch.com and 855-592-8507, Monday to Friday, 9AM to 5PM Eastern. How it compares with other Klow sellers is in Where to Buy Klow Peptide Online.
Is Klow a prescription drug?
No. It isn’t an approved medicine, so no pharmacy fills it; Simms Research sells it as a freeze-dried blend for laboratory research.
Is there a discount code on this page?
No. This page carries no discount code and no affiliate link.